Deutsche Bank Ag\ Novavax Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Novavax Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 83,794 shares of NVAX stock, worth $675,379. This represents 0.0% of its overall portfolio holdings.

Number of Shares

83,794

Previous 65,222 28.48%

Holding current value

$675,379

Previous $825,000 28.24%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.71 - $17.11 $198,906 - $317,766	18,572 Added 28.48%	83,794 $1.06 Million
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $28,797 - $155,240	7,403 Added 12.8%	65,222 $825,000
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $43,811 - $70,145	11,652 Added 25.24%	57,819 $276,000
Q4 2023 Feb 14, 2024	SELL	$4.8 - $7.67 $3,532 - $5,645	-736 Reduced 1.57%	46,167 $221,000
Q3 2023 Nov 09, 2023	BUY	$6.81 - $9.74 $37,557 - $53,716	5,515 Added 13.33%	46,903 $339,000
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $184,959 - $263,989	27,730 Added 203.03%	41,388 $307,000
Q1 2023 May 15, 2023	SELL	$5.76 - $12.48 $335,272 - $726,423	-58,207 Reduced 80.99%	13,658 $94,000
Q4 2022 Feb 13, 2023	BUY	$8.86 - $25.04 $45,044 - $127,303	5,084 Added 7.61%	71,865 $738,000
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $202,820 - $848,281	-11,144 Reduced 14.3%	66,781 $1.22 Million
Q2 2022 Aug 11, 2022	SELL	$36.28 - $75.29 $4.35 Million - $9.03 Million	-119,957 Reduced 60.62%	77,925 $4.01 Million
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $1.82 Million - $3.72 Million	26,037 Added 15.15%	197,882 $14.6 Million
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $7.23 Million - $11.7 Million	53,766 Added 45.53%	171,845 $24.6 Million
Q3 2021 Nov 04, 2021	SELL	$177.8 - $270.58 $345,465 - $525,736	-1,943 Reduced 1.62%	118,079 $24.5 Million
Q2 2021 Aug 11, 2021	BUY	$121.0 - $257.67 $5.48 Million - $11.7 Million	45,305 Added 60.64%	120,022 $25.5 Million
Q1 2021 May 13, 2021	SELL	$112.98 - $319.93 $258,837 - $732,959	-2,291 Reduced 2.98%	74,717 $13.5 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $2.9 Million - $5.13 Million	36,808 Added 91.56%	77,008 $8.59 Million
Q3 2020 Nov 12, 2020	BUY	$79.44 - $178.51 $459,163 - $1.03 Million	5,780 Added 16.79%	40,200 $4.36 Million
Q2 2020 Aug 13, 2020	BUY	$13.86 - $83.61 $333,346 - $2.01 Million	24,051 Added 231.95%	34,420 $2.87 Million
Q1 2020 May 14, 2020	BUY	$3.93 - $16.0 $5,002 - $20,368	1,273 Added 14.0%	10,369 $141,000
Q4 2019 Feb 14, 2020	BUY	$3.69 - $5.22 $10,498 - $14,850	2,845 Added 45.51%	9,096 $35,000
Q3 2019 Nov 14, 2019	SELL	$4.02 - $7.84 $300,736 - $586,510	-74,810 Reduced 92.29%	6,251 $30,000
Q2 2019 Aug 14, 2019	BUY	$4.93 - $12.2 $399,630 - $988,944	81,061 New	81,061 $474,000

Others Institutions Holding NVAX

# of Institutions

292

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account